I am a postdoctoral fellow at the Program for Evolutionary Dynamics at Harvard University studying HIV treatment by antiretoviral (ARV) drugs with Alison Hill. My research focuses on modelling the ARVs to predict their distribution in the body, specifically HIV reservoir sites, to optimise their use. One of the primary goals of my work is to improve outcomes by understanding how the use of ARVs impacts HIV resistance and the evolution of HIV in the body. We study improved drug delivery methods in relation to currently available treatments to quantify their impact on imperfect adherence, with an eye on an HIV cure. I also study hematopoietic stem cell and neutrophil regulation dynamics, together with mechanistic pharmacokinetic and pharmacodynamic models of exo- and endogenous cytokines. My work is rooted in mathematical/systems biology and quantitative systems pharmacology.
I have a PhD in pharmaceutical sciences from l'Université de Montréal's Faculté de Pharmacie, co-supervised by Fahima Nekka and Michael Mackey, and an MSc in mathematics from the University of Manitoba, supervised by Stéphanie Portet.
A copy of my CV (as of February 2017) is available here.